blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4215621

EP4215621 - QUANTIFICATION OF NUCLEOSOME MODIFICATIONS USING CHEMICALLY-DEFINED RECOMBINANT NUCLEOSOMES [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  13.08.2024
Database last updated on 19.10.2024
FormerExamination is in progress
Status updated on  16.02.2024
FormerRequest for examination was made
Status updated on  26.01.2024
FormerThe application has been published
Status updated on  23.06.2023
Most recent event   Tooltip13.08.2024New entry: Communication of intention to grant a patent 
Applicant(s)For all designated states
Epicypher, Inc.
801 Capitola Drive
Suite 9
Research Triangle Park, North Carolina 27713 / US
[2023/30]
Inventor(s)01 / JOHNSTONE, Andrea L
Durham / US
02 / COWLES, Martis William
Durham / US
03 / WHELIHAN, Matthew F
Durham / US
04 / MARUNDE, Matthew R
Durham / US
05 / KOEGH, Michael-Christopher
Durham / US
06 / HALL, Nathan W
Durham / US
07 / SUN, Zu-Wen
Durham / US
 [2023/30]
Representative(s)Appleyard Lees IP LLP
15 Clare Road
Halifax HX1 2HY / GB
[2023/30]
Application number, filing date23157465.801.03.2019
[2023/30]
Priority number, dateUS201862637066P01.03.2018         Original published format: US 201862637066 P
[2023/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4215621
Date:26.07.2023
Language:EN
[2023/30]
Search report(s)(Supplementary) European search report - dispatched on:EP01.06.2023
ClassificationIPC:C12Q1/6851, C12Q1/6804, G01N33/53, G01N33/68, C12Q1/6806
[2023/30]
CPC:
G01N33/6875 (EP); C12Q1/6804 (EP,US); C12Q1/6806 (EP);
C12Q1/6811 (US); C12Q1/6883 (EP); G01N33/49 (US);
C12Q2600/118 (EP); C12Q2600/156 (EP); C12Y301/31001 (US);
G01N2440/18 (EP) (-)
C-Set:
C12Q1/6804, C12Q2521/301, C12Q2522/10, C12Q2545/113 (EP);
C12Q1/6804, C12Q2522/10, C12Q2545/101 (EP);
C12Q1/6806, C12Q2521/301, C12Q2522/10, C12Q2545/113 (EP);
C12Q1/6806, C12Q2522/10, C12Q2545/101 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/09]
Former [2023/30]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:QUANTIFIZIERUNG VON NUKLEOSOMMODIFIKATIONEN MIT CHEMISCH DEFINIERTEN REKOMBINANTEN NUKLEOSOMEN[2023/30]
English:QUANTIFICATION OF NUCLEOSOME MODIFICATIONS USING CHEMICALLY-DEFINED RECOMBINANT NUCLEOSOMES[2023/30]
French:QUANTIFICATION DE MODIFICATIONS DE NUCLÉOSOMES À L'AIDE DE NUCLÉOSOMES RECOMBINANTS DÉFINIS CHIMIQUEMENT[2023/30]
Examination procedure24.01.2024Examination requested  [2024/09]
24.01.2024Date on which the examining division has become responsible
14.02.2024Despatch of a communication from the examining division (Time limit: M04)
24.05.2024Reply to a communication from the examining division
14.08.2024Communication of intention to grant the patent
Parent application(s)   TooltipEP19760658.5  / EP3759249
Fees paidRenewal fee
20.02.2023Renewal fee patent year 03
20.02.2023Renewal fee patent year 04
27.02.2023Renewal fee patent year 05
03.01.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2005019826  (CHROMA THERAPEUTICS LTD [GB], et al);
 [A]WO2015104431  (PROTEROS BIOSTRUCTURES GMBH [DE]);
 [A]WO2015117145  (UNIV CHICAGO [US]);
 [A]WO2017034970  (MASSACHUSETTS GEN HOSPITAL [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.